Floatz logo

GLUCAGON-LIKE PEPTIDE 1, HUMAN

Pancreatic Insufficiency

University of Pennsylvaniaprotein_peptideN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Pancreatic Insufficiency cohort.

Asset / SponsorPhaseRating
Liprotamase
Anthera Pharmaceuticals
Phase 4A
Pancrelipase
Anagram Therapeutics, Inc.
Phase 4A
Porcine Pert
Entero Therapeutics
Phase 3BB
Triheptadecanoin
Children's Hospital of Philadelphia
Phase 4BB
Panzytrat
Forest Laboratories
Phase 4BB

View all 26 →

Same molecule, other indications

GLUCAGON-LIKE PEPTIDE 1, HUMAN is also rated in:

polycystic ovary syndromeDormant
CCC
Indicative ·
53 / 100
View asset →
type 2 diabetes mellitusDormant
CC
Indicative ·
42 / 100
View asset →
obesity disorderDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →